FDA Approves Self-Injection of Vyvgart Hytrulo

WEDNESDAY, April 16, 2025-- The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the treatment of adult patients with generalized myasthenia gravis (gMG) who...